| Allergic rhinitis and its impact on asthma (ARIA) 2008 J Bousquet, N Khaltaev, AA Cruz, J Denburg, WJ Fokkens, A Togias, ... Allergy 63, 8-160, 2008 | 10572* | 2008 |
| Global strategy for asthma management and prevention: GINA executive summary ED Bateman, SS Hurd, PJ Barnes, J Bousquet, JM Drazen, M FitzGerald, ... European Respiratory Journal 31 (1), 143-178, 2008 | 3884 | 2008 |
| Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision JL Brożek, J Bousquet, CE Baena-Cagnani, S Bonini, GW Canonica, ... Journal of Allergy and Clinical Immunology 126 (3), 466-476, 2010 | 3179* | 2010 |
| Eosinophilic inflammation in asthma J Bousquet, P Chanez, JY Lacoste, G Barnéon, N Ghavanian, I Enander, ... New England Journal of Medicine 323 (15), 1033-1039, 1990 | 3151 | 1990 |
| Asthma: from bronchoconstriction to airways inflammation and remodeling J Bousquet, PK Jeffery, WW Busse, M Johnson, AM Vignola American journal of respiratory and critical care medicine 161 (5), 1720-1745, 2000 | 2642 | 2000 |
| A revised nomenclature for allergy: an EAACI position statement from the EAACI nomenclature task force SGO Johansson, JOB Hourihane, J Bousquet, C Bruijnzeel‐Koomen, ... Allergy 56 (9), 813-824, 2001 | 2347 | 2001 |
| Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study ED Bateman, HA Boushey, J Bousquet, WW Busse, TJH Clark, ... American journal of respiratory and critical care medicine 170 (8), 836-844, 2004 | 2224 | 2004 |
| Allergen immunotherapy: therapeutic vaccines for allergic diseases A WHO position paper J Bousquet, R Lockey, HJ Malling Journal of Allergy and Clinical Immunology 102 (4), 558-562, 1998 | 1797* | 1998 |
| Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment … M Humbert, R Beasley, J Ayres, R Slavin, J Hébert, J Bousquet, KM Beeh, ... Allergy 60 (3), 309-316, 2005 | 1287 | 2005 |
| Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach AA Cruz World Health Organization, 2007 | 1043 | 2007 |
| Induction of nitric oxide synthase in asthma Q Hamid, DR Springall, JM Polak, V Riveros-Moreno, P Chanez, ... The Lancet 342 (8886-8887), 1510-1513, 1993 | 1016 | 1993 |
| Chronic rhinosinusitis in Europe – an underestimated disease. A GA2LEN study D Hastan, WJ Fokkens, C Bachert, RB Newson, J Bislimovska, ... Allergy 66 (9), 1216-1223, 2011 | 1002 | 2011 |
| Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS) European Community Respiratory Health Survey Eur Respir J 9, 687-695, 1996 | 980 | 1996 |
| Identifying ‘well-controlled’and ‘not well-controlled’asthma using the Asthma Control Questionnaire EF Juniper, J Bousquet, L Abetz, ED Bateman, Goal Committee Respiratory medicine 100 (4), 616-621, 2006 | 955 | 2006 |
| Consensus statement on the treatment of allergic rhinitis P Van Cauwenberge, C Bachert, G Passalacqua, J Bousquet, ... Allergy 55 (2), 116-134, 2000 | 943 | 2000 |
| Grading quality of evidence and strength of recommendations in clinical practice guidelines: part 1 of 3. An overview of the GRADE approach and grading quality of evidence … JL Brożek, EA Akl, P Alonso‐Coello, D Lang, R Jaeschke, JW Williams, ... Allergy 64 (5), 669-677, 2009 | 919* | 2009 |
| Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma J Bousquet, E Mantzouranis, AA Cruz, N Aït-Khaled, CE Baena-Cagnani, ... Journal of Allergy and Clinical Immunology 126 (5), 926-938, 2010 | 905 | 2010 |
| Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report1 M Maurer, K Weller, C Bindslev‐Jensen, A Giménez‐Arnau, PJ Bousquet, ... Allergy 66 (3), 317-330, 2011 | 820 | 2011 |
| WHO position paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases J Bousquet Allergy 53 (44), 1-42, 1998 | 802 | 1998 |
| Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children A Des Roches, L Paradis, JL Menardo, S Bouges, JP Daurés, J Bousquet Journal of allergy and clinical immunology 99 (4), 450-453, 1997 | 784 | 1997 |
